Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Schrodinger stock

SDGR
US80810D1037
A2PY7M

Price

19.73
Today +/-
-0.03
Today %
-0.15 %

Schrodinger stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Schrodinger stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Schrodinger stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Schrodinger stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Schrodinger's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Schrodinger Stock Price History

DateSchrodinger Price
12/24/202419.73 undefined
12/23/202419.76 undefined
12/20/202419.44 undefined
12/19/202419.30 undefined
12/18/202419.74 undefined
12/17/202421.36 undefined
12/16/202421.64 undefined
12/13/202420.83 undefined
12/12/202421.07 undefined
12/11/202421.76 undefined
12/10/202422.11 undefined
12/9/202421.67 undefined
12/6/202421.84 undefined
12/5/202420.63 undefined
12/4/202422.23 undefined
12/3/202421.95 undefined
12/2/202422.48 undefined
11/29/202422.57 undefined
11/27/202422.01 undefined

Schrodinger Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Schrodinger, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Schrodinger from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Schrodinger’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Schrodinger. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Schrodinger’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Schrodinger’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Schrodinger’s growth potential.

Schrodinger Revenue, EBIT and net profit per share

DateSchrodinger RevenueSchrodinger EBITSchrodinger Net Income
2029e565.55 M undefined74.84 M undefined0 undefined
2028e460.9 M undefined-70.56 M undefined0 undefined
2027e353.35 M undefined-105.44 M undefined285.38 M undefined
2026e313.07 M undefined-169.77 M undefined-161.16 M undefined
2025e261.48 M undefined-195.18 M undefined-182.19 M undefined
2024e206.7 M undefined-224.39 M undefined-175.92 M undefined
2023216.67 M undefined-177.45 M undefined40.72 M undefined
2022181 M undefined-146.8 M undefined-149.2 M undefined
2021137.9 M undefined-111.4 M undefined-100.4 M undefined
2020108.1 M undefined-60.9 M undefined-24.5 M undefined
201985.5 M undefined-38.7 M undefined-24.6 M undefined
201866.6 M undefined-28 M undefined-28.4 M undefined
201755.7 M undefined-19 M undefined-17.4 M undefined

Schrodinger Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024e2025e2026e2027e2028e2029e
556685108137181216206261313353460565
-20.0028.7927.0626.8532.1219.34-4.6326.7019.9212.7830.3122.83
70.9163.6457.6558.3347.4555.8064.8167.9653.6444.7339.6630.4324.78
3942496365101140000000
-17-28-24-24-100-14940-175-182-16128500
-64.71-14.29-316.6749.00-126.85-537.504.00-11.54-277.02--
61.461.461.46070.671.274.99000000
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Schrodinger Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Schrodinger is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2017201820192020202120222023
             
36.384.185.8642.7576.5451.1463
9.81825.6354067.387.1
000.10.40.61.82.02
0000000
22.674.9813.815.68
48.1104.7118.5683625.1534567.8
5.481915.385.4120.2141.1
2.65.415.445.743.225.783.25
0000000
10000006000
000004.84.79
1.92.62.32.42.93.36.01
101636.763.4131.5154.6235.16
58.1120.7155.2746.4756.6688.6802.96
             
82.4161.8191.70.70.70.70.72
6.78.911.7752.6787828.7885.97
-52.1-80.5-105.1-129.6-230-379.1-338.42
000300-700-2,400281
0000000
3790.298.3624557447.9548.56
1.62.83.58.48.19.516.82
5.16.616.419.427.841.160.63
11.217.625.145.455.458.356.23
0000000
0000000
17.9274573.291.3108.9133.67
0000000
0000000
3.33.61249108.2131.9120.72
3.33.61249108.2131.9120.72
21.230.657122.2199.5240.8254.4
58.2120.8155.3746.2756.5688.7802.95
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Schrodinger provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Schrodinger's financial health and stability.

Assets

Schrodinger's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Schrodinger must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Schrodinger after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Schrodinger's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
-17-28-25-26-101-14940
1233245
0000000
104594-21-22
02-6-84986-112
0000000
0000002
-15-23-2616-70-119-136
-3-5-1-2-7-8-13
211-53-381-1690193
516-52-379-998206
0000000
0000000
18030541729
18028541729
---1.00----
0000000
-1267-51176-79-2765
-19.01-28.97-27.914.22-77.84-127.69-150.14
0000000

Schrodinger stock margins

The Schrodinger margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Schrodinger. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Schrodinger.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Schrodinger's sales revenue. A higher gross margin percentage indicates that the Schrodinger retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Schrodinger's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Schrodinger's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Schrodinger's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Schrodinger. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Schrodinger's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Schrodinger Margin History

Schrodinger Gross marginSchrodinger Profit marginSchrodinger EBIT marginSchrodinger Profit margin
2029e64.93 %13.23 %0 %
2028e64.93 %-15.31 %0 %
2027e64.93 %-29.84 %80.76 %
2026e64.93 %-54.23 %-51.48 %
2025e64.93 %-74.65 %-69.68 %
2024e64.93 %-108.56 %-85.11 %
202364.93 %-81.9 %18.79 %
202255.8 %-81.1 %-82.43 %
202147.57 %-80.78 %-72.81 %
202058.74 %-56.34 %-22.66 %
201957.43 %-45.26 %-28.77 %
201864.41 %-42.04 %-42.64 %
201771.45 %-34.11 %-31.24 %

Schrodinger Stock Sales Revenue, EBIT, Earnings per Share

The Schrodinger earnings per share therefore indicates how much revenue Schrodinger has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Schrodinger earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Schrodinger's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Schrodinger’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Schrodinger's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Schrodinger Revenue, EBIT and net profit per share

DateSchrodinger Sales per ShareSchrodinger EBIT per shareSchrodinger Earnings per Share
2029e7.76 undefined0 undefined0 undefined
2028e6.33 undefined0 undefined0 undefined
2027e4.85 undefined0 undefined3.92 undefined
2026e4.3 undefined0 undefined-2.21 undefined
2025e3.59 undefined0 undefined-2.5 undefined
2024e2.84 undefined0 undefined-2.41 undefined
20232.89 undefined-2.37 undefined0.54 undefined
20222.54 undefined-2.06 undefined-2.1 undefined
20211.95 undefined-1.58 undefined-1.42 undefined
20201.8 undefined-1.02 undefined-0.41 undefined
20191.39 undefined-0.63 undefined-0.4 undefined
20181.08 undefined-0.46 undefined-0.46 undefined
20170.91 undefined-0.31 undefined-0.28 undefined

Schrodinger business model

Schrodinger Inc is a leading company in the field of computational molecular dynamics and computer-aided drug design. The company was founded in 1990 by Erich Schneider and Richard Friesner in New York City. In its early years, the company focused on creating simulations of chemical reactions and understanding how molecules interact. Since then, Schrodinger Inc has expanded its products and services. One of their important services is computer-aided drug design. The company has developed a successful strategy to accelerate and optimize drug development programs for biopharmaceutical companies and academic institutions. The business model of Schrodinger Inc is based on providing software tools for scientists, industry companies, and academic institutions. The company specializes in developing software for molecular modeling and calculating properties of molecules, such as predicting accuracy in ligand binding to proteins. Their products enable researchers to perform simulations and analyze data for better prediction of molecular structure and interactions with other molecules. Schrodinger Inc also offers a wide range of products specialized in drug development. These include tools for calculating molecular properties of compounds, such as lipophilicity, polarity, and hydrogen bonding. The software tools also provide options for exchanging interactive conformations of molecules and identifying unique molecular properties to enhance binding to target proteins. Another product offering from Schrodinger Inc is the so-called "Discovery Units" - specialized units that focus on specific applications and therapeutic areas. These Discovery Units can encompass biopharmaceuticals, drugs for specific diseases, or groups of diseases. Through these units, customers can access specialized software products and personalized services. Overall, Schrodinger Inc is a pioneer company in the computer simulation of molecules and computer-aided drug design. For the future, Schrodinger Inc plans to expand its offering of personalized services and utilize AI technologies to enhance models and algorithms for drug discovery. Schrodinger is one of the most popular companies on Eulerpool.com.

Schrodinger SWOT Analysis

Strengths

Schrodinger Inc possesses several strengths that contribute to its success and market position. These include:

  • A strong team of experienced scientists and researchers
  • Advanced technology platforms for drug discovery
  • Strong intellectual property portfolio
  • Collaborations with leading pharmaceutical companies
  • Robust financial performance and stable revenue streams

Weaknesses

Despite its strengths, Schrodinger Inc also faces some weaknesses that need to be addressed in order to maintain its competitive edge:

  • Limited operational scale compared to larger competitors
  • Dependence on key clients and partnerships
  • Relatively high research and development costs
  • Exposure to regulatory and compliance risks
  • Challenges in penetrating emerging markets

Opportunities

Several opportunities exist for Schrodinger Inc to further expand and enhance its business:

  • Increasing demand for innovative drug discovery solutions
  • Growing healthcare market and investments in research and development
  • Exploring partnerships with biotech startups and academic institutions
  • Expanding presence in emerging markets with favorable regulatory environments
  • Leveraging AI and machine learning technologies in drug discovery

Threats

Schrodinger Inc should also be aware of the following threats that may pose challenges to its success:

  • Intense competition from established pharmaceutical companies
  • Rapidly changing regulatory landscape
  • Uncertainty in government funding for research and development
  • Potential disruptions in supply chains and manufacturing processes
  • Risks associated with data privacy and cybersecurity

Schrodinger Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Schrodinger Revenue by Segment

Segmente202320212020
Software products and services159.12 M USD113.24 M USD92.53 M USD
Drug discovery2.82 M USD24.7 M USD15.57 M USD

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Schrodinger Revenue by Segment

Segmente202320212020
On premise software-74.6 M USD58.31 M USD
On-premise software104.51 M USD--

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Schrodinger Revenue by Segment

Segmente202320212020
Revenue from contracts with customers157.32 M USD--
Software maintenance23.07 M USD--
Hosted software20.38 M USD--
Professional services9.37 M USD--
Software contribution1.8 M USD--

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Schrodinger Revenue by Segment

Segmente202320212020
Revenue from contract with customer before software contribution-112.24 M USD-
Revenue from contract with customer before contribution--91.53 M USD
Software Maintenance-17.29 M USD14.47 M USD
Hosted software-11.08 M USD9.19 M USD
Professional services-9.27 M USD9.56 M USD
Software contribution-1 M USD-
Contribution--1 M USD

Schrodinger Revenue by Region

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Schrodinger Revenue by Segment

DateAPACEMEAEuropeJapanRest of WorldUnited States
202324.57 M USD29.14 M USD--1 M USD161.96 M USD
2021--27.81 M USD8.57 M USD11.16 M USD90.4 M USD
2020--24.37 M USD14.56 M USD8.43 M USD60.74 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Schrodinger Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Schrodinger historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Schrodinger shares outstanding

The number of shares was Schrodinger in 2023 — This indicates how many shares 74.987 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Schrodinger earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Schrodinger's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Schrodinger’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Schrodinger's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Schrodinger.

Schrodinger latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.61 -0.52  (14.46 %)2024 Q3
6/30/2024-0.87 -0.74  (14.87 %)2024 Q2
3/31/2024-0.76 -0.76  (0.48 %)2024 Q1
12/31/2023-0.38 -0.41  (-6.55 %)2023 Q4
9/30/2023-0.72 -0.86  (-18.65 %)2023 Q3
6/30/2023-0.48 0.06  (112.57 %)2023 Q2
3/31/20231.34 1.75  (30.63 %)2023 Q1
12/31/2022-0.54 -0.38  (29.88 %)2022 Q4
9/30/2022-0.66 -0.56  (15.2 %)2022 Q3
6/30/2022-0.63 -0.67  (-7.15 %)2022 Q2
1
2

Eulerpool ESG Scorecard© for the Schrodinger stock

Eulerpool World ESG Rating (EESG©)

62/ 100

🌱 Environment

32

👫 Social

79

🏛️ Governance

75

Environment

Scope 1 - Direct Emissions
249
Scope 2 - Indirect emissions from purchased energy
901
Scope 3 - Indirect emissions within the value chain
31,431
Total CO₂ emissions
1,150
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees32.5
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Schrodinger shareholders

%
Name
Stocks
Change
Date
10.79149 % BlackRock Institutional Trust Company, N.A.7,862,680-29,0746/30/2024
9.58230 % Bill & Melinda Gates Foundation Trust6,981,66406/30/2024
9.37722 % The Vanguard Group, Inc.6,832,24135,8186/30/2024
4.29591 % Rubric Capital Management LP3,130,0002,131,7246/30/2024
3.35936 % ARK Investment Management LLC2,447,629-70,3566/30/2024
2.96615 % Nikko Asset Management Co., Ltd.2,161,134-31,8386/30/2024
2.91651 % Baillie Gifford & Co.2,124,968-487,0396/30/2024
2.90509 % State Street Global Advisors (US)2,116,6487,8156/30/2024
2.82481 % UBS Asset Management (UK) Ltd.2,058,1552,022,6316/30/2024
2.11346 % Stephens Investment Management Group, LLC1,539,870436,7899/30/2024
1
2
3
4
5
...
10

Schrodinger Executives and Management Board

Mr. Kenneth Lorton

(39)
Schrodinger Executive Vice President, Chief Technology Officer
Compensation 4.49 M

Dr. Ramy Farid

(58)
Schrodinger President, Chief Executive Officer, Director (since 2008)
Compensation 3.92 M

Mr. Geoffrey Porges

(62)
Schrodinger Chief Financial Officer, Executive Vice President
Compensation 3.25 M

Dr. Karen Akinsanya

(55)
Schrodinger President - R&D Therapeutics
Compensation 1.85 M

Ms. Yvonne Tran

(52)
Schrodinger Executive Vice President, Chief Legal Officer, Corporate Secretary
Compensation 1.47 M
1
2
3

Schrodinger Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Thermo Fisher Scientific Stock
Thermo Fisher Scientific
SupplierCustomer0,900,790,690,71-0,36-0,61
AstraZeneca Stock
AstraZeneca
SupplierCustomer0,680,78-0,45-0,40-0,50-0,69
Viva Biotech Stock
Viva Biotech
SupplierCustomer0,550,780,840,560,940,72
NVIDIA Stock
NVIDIA
SupplierCustomer0,550,790,960,84-0,30-0,64
Credit Suisse Group Stock
Credit Suisse Group
SupplierCustomer0,490,650,880,440,710,81
Takeda Pharmaceutical Stock
Takeda Pharmaceutical
SupplierCustomer0,480,12-0,62-0,600,370,51
Ono Pharmaceutical Stock
Ono Pharmaceutical
SupplierCustomer0,44-0,10-0,69-0,54-0,720,04
Merck & Co Stock
Merck & Co
SupplierCustomer0,41-0,20-0,72-0,61-0,42-0,58
Morphic Holding Stock
Morphic Holding
SupplierCustomer0,400,710,920,750,870,09
Sun Pharma Advanced Rsch Stock
Sun Pharma Advanced Rsch
SupplierCustomer0,390,680,790,01-0,26-0,63
1

Most common questions regarding Schrodinger

What values and corporate philosophy does Schrodinger represent?

Schrodinger Inc represents a set of core values and a strong corporate philosophy. The company focuses on delivering innovative solutions in the field of computational chemistry and advancing drug discovery and materials science. Schrodinger Inc believes in a multidisciplinary approach, combining scientific expertise with cutting-edge technology to empower researchers and accelerate scientific breakthroughs. With a commitment to collaboration, integrity, and excellence, Schrodinger Inc aims to transform the way pharmaceutical and biotechnology industries approach research and development. By harnessing the power of physics-based simulations and computational models, Schrodinger Inc strives to revolutionize drug discovery and contribute to the advancement of human health.

In which countries and regions is Schrodinger primarily present?

Schrodinger Inc is primarily present worldwide, with a strong presence in North America, Europe, and Asia. The company's global reach allows it to serve customers and collaborate with partners across borders. Schrodinger Inc's diverse international presence helps foster innovation and the development of cutting-edge computational tools for drug discovery and materials science.

What significant milestones has the company Schrodinger achieved?

Schrodinger Inc, a renowned company specializing in computational drug discovery, has achieved significant milestones since its inception. The company has developed innovative software solutions and platforms, including the widely acclaimed Schrodinger Suite, which revolutionizes drug discovery processes. Schrodinger Inc has collaborated with prominent pharmaceutical companies, accelerated drug discovery initiatives, and contributed to the development of breakthrough therapies. With its cutting-edge technologies and expertise, the company has successfully advanced multiple drug discovery programs, addressing critical diseases and meeting the evolving needs of the pharmaceutical industry. Schrodinger Inc continues to pave the way in computational chemistry, providing valuable solutions for drug designers and researchers worldwide.

What is the history and background of the company Schrodinger?

Schrodinger Inc is a renowned chemical simulation and computational drug discovery company. Established in 1990, it has been a pioneer in utilizing physics-based algorithms to accelerate the discovery and development of novel drugs. With a strong focus on research and technology innovation, Schrodinger Inc has emerged as a leader in the field, providing cutting-edge solutions to leading pharmaceutical and biotechnology companies worldwide. By leveraging advanced computational techniques, including molecular dynamics simulations and quantum mechanics, the company enables scientists to gain valuable insights into drug-target interactions, leading to the identification of potential therapeutics. Schrodinger Inc's rich history and expertise make it a trusted partner in accelerating the drug discovery process.

Who are the main competitors of Schrodinger in the market?

The main competitors of Schrodinger Inc in the market are companies like OpenEye Scientific Software, BioSolveIT, and Chemical Computing Group.

In which industries is Schrodinger primarily active?

Schrodinger Inc is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Schrodinger?

The business model of Schrodinger Inc revolves around computational drug discovery. As a leading company in the field, Schrodinger Inc integrates physics-based simulations and machine learning to facilitate faster and more efficient drug development. By leveraging their innovative software platforms, such as Schrodinger Suite, the company enables biopharmaceutical companies to optimize drug discovery and development processes. Schrodinger Inc's approach allows for the generation of highly accurate computational models of drug-target interactions, aiding in the identification of promising drug candidates. With a strong focus on collaboration and scientific expertise, Schrodinger Inc continues to offer valuable solutions for the pharmaceutical industry.

What is the P/E ratio of Schrodinger 2024?

The Schrodinger P/E ratio is -8.41.

What is the P/S ratio of Schrodinger 2024?

The Schrodinger P/S ratio is 7.16.

What is the Quality Investing of Schrodinger?

The Quality Investing for Schrodinger is 3/10.

What is the revenue of Schrodinger 2024?

The expected Schrodinger revenue is 206.7 M USD.

How high is the profit of Schrodinger 2024?

The expected Schrodinger profit is -175.92 M USD.

What is the business model of Schrodinger

Schrodinger Inc. is a biomedical company based in the United States that specializes in using computer simulations for the development of drugs and chemicals. The company was founded in 1990 by Dr. William L. Jorgensen and is headquartered in New York City. Schrodinger Inc.'s business model is based on the development of simulation software used to accelerate the drug development process, as well as the development of pesticides and other chemicals. The company offers software and services in the fields of medicinal chemistry, materials science, biology, and toxicology. Some of its software products include the Schrödinger Suite, a leading package for molecular simulations and modeling. In addition, the company offers a cloud-based platform called LiveDesign, which allows customers to collaborate with the Schrodinger team securely. Through this platform, users can access data and models in real-time to make faster decisions and achieve multiple goals in shorter timeframes. In the field of drug development, Schrodinger Inc. also offers compute-based services. The company provides its customers with a data-driven approach to identify drug candidates and optimize their pharmacological properties, allowing for faster identification of active ingredients and saving time and money. Additionally, Schrodinger Inc. is capable of delivering its software and services as cloud-based platforms to customers in the biotechnology industry who have limited IT resources. Customers can utilize a private cloud to host their own data and applications, gaining access to a scalable and flexible infrastructure that can quickly and efficiently respond to industry demands. With its innovative and effective technology supporting drug development, Schrodinger Inc. has established itself as a trusted provider of computer-based solutions in the pharmaceutical and biotechnology industries. With a strong focus on research and development, the company remains at the forefront of the industry and is well-positioned to continue growing and expanding.

What is the Schrodinger dividend?

Schrodinger pays a dividend of 0 USD distributed over payouts per year.

How often does Schrodinger pay dividends?

The dividend cannot currently be calculated for Schrodinger or the company does not pay out a dividend.

What is the Schrodinger ISIN?

The ISIN of Schrodinger is US80810D1037.

What is the Schrodinger WKN?

The WKN of Schrodinger is A2PY7M.

What is the Schrodinger ticker?

The ticker of Schrodinger is SDGR.

How much dividend does Schrodinger pay?

Over the past 12 months, Schrodinger paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Schrodinger is expected to pay a dividend of 0 USD.

What is the dividend yield of Schrodinger?

The current dividend yield of Schrodinger is .

When does Schrodinger pay dividends?

Schrodinger pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Schrodinger?

Schrodinger paid dividends every year for the past 0 years.

What is the dividend of Schrodinger?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Schrodinger located?

Schrodinger is assigned to the 'Health' sector.

Wann musste ich die Aktien von Schrodinger kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Schrodinger from 12/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/26/2024.

When did Schrodinger pay the last dividend?

The last dividend was paid out on 12/26/2024.

What was the dividend of Schrodinger in the year 2023?

In the year 2023, Schrodinger distributed 0 USD as dividends.

In which currency does Schrodinger pay out the dividend?

The dividends of Schrodinger are distributed in USD.

All fundamentals about Schrodinger

Our stock analysis for Schrodinger Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Schrodinger Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.